Traws Pharma, Inc. Stock Split Ratio
Traws Pharma, Inc. (TRAW) reported Stock Split Ratio of 4.00% for the 1-month period ending 2024-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2025-11-13
- 2024-09-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 4.00%.
- 2021-05-20: Stockholders' Equity Note, Stock Split, Conversion Ratio 6.70%.
- 2018-09-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 6.67%.
- 2018-09-25: Stockholders' Equity Note, Stock Split, Conversion Ratio 6.70%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|---|---|
| 2024-09-30 | 4.00% 10-Q · filed 2025-11-13 | ||
| 2021-05-20 | 6.70% 10-K · filed 2023-03-30 | ||
| 2018-09-30 | 6.67% 10-Q · filed 2021-08-16 | ||
| 2018-09-25 | 6.70% 10-K · filed 2020-03-27 | ||
| 2016-05-31 | 10.00% 10-K · filed 2018-03-16 | ||
| 2013-07-17 | 75.00% 10-K · filed 2015-03-30 | 75.00% 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |